靶向PKM2依赖的糖酵解重编程单核细胞为Cadm1+巨噬细胞促进黏膜修复并减轻结肠炎进展
本研究旨在探索调控巨噬细胞代谢能否促进溃疡性结肠炎(UC)黏膜愈合而不驱动肿瘤发生。通过多组学数据集和三项临床UC研究筛选靶点,并利用巨噬细胞特异性PKM2敲除小鼠、单细胞与空间转录组及人巨噬细胞-结肠类器官共培养模型验证。结果显示,UC患者损伤区肠道巨噬细胞糖酵解显著上调,PKM2表达与疾病严重度和复发率增加相关;PKM2缺失促进单核细胞分化为修复性Cadm1+巨噬细胞,经PGE2/EP4轴增强Lgr5+干细胞自我更新,改善小鼠结肠炎并抑制肿瘤发生。
要点
- UC患者损伤区肠道巨噬细胞糖酵解显著上调,PKM2表达与疾病严重度和复发率增加相关。
- 巨噬细胞PKM2缺失促进单核细胞分化为Cadm1+巨噬细胞,经PGE2/EP4轴增强Lgr5+干细胞自我更新。
- 靶向巨噬细胞PKM2依赖的糖酵解可促进黏膜愈合且不驱动肿瘤发生。
核心结论
- 靶向巨噬细胞PKM2依赖的糖酵解可增强Cadm1+巨噬细胞介导的黏膜愈合,且不驱动肿瘤发生。
研究设计与样本
- 研究通过多组学数据集和三项临床UC研究评估与UC疾病活动度和复发相关的潜在治疗靶点。
- 利用巨噬细胞特异性PKM2敲除小鼠、单细胞与空间转录组分析及人巨噬细胞-结肠类器官共培养模型验证功能与机制。
主要发现
- UC患者损伤区肠道巨噬细胞糖酵解显著上调,PKM2表达与疾病严重度增加和复发率更高相关。
- 小鼠巨噬细胞PKM2缺失增强肠道屏障功能并改善结肠炎进展。
- PKM2缺陷促进单核细胞分化为修复性Cadm1+巨噬细胞,并经PGE2/EP4轴增强Lgr5+干细胞自我更新。
- 人STAB1+巨噬细胞与小鼠Cadm1+巨噬细胞转录组和代谢相似,与UC缓解及结直肠癌中CD8+ T细胞空间分布正相关。
- 小鼠巨噬细胞PKM2缺失大幅抑制肿瘤发生,伴Cadm1+巨噬细胞丰度增加和CD8+ T细胞浸润增强。
临床怎么用
- 靶向肠道巨噬细胞PKM2可能成为促进UC黏膜愈合且不增加肿瘤风险的治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Incomplete mucosal healing contributes to progression and relapse in ulcerative colitis (UC). Currently, therapeutic strategies that promote mucosal healing and regeneration are limited and may potentiate oncogenic transformation. OBJECTIVE: We aimed to identify whether modulating macrophage metabolism may facilitate mucosal healing without driving tumourigenesis. DESIGN: Potential therapeutic targets associated with UC disease activity and relapse were assessed in multiple omics datasets and three clinical UC studies. The function and mechanism of macrophage pyruvate kinase M2 (PKM2) in UC progression were demonstrated by macrophage-specific PKM2 knockout mice, single-cell and spatial transcriptomic profiling, and human macrophage-colonic organoid coculture models. RESULTS: Glycolysis was markedly upregulated in intestinal macrophages within damaged regions in UC patients, whereas PKM2 expression was associated with increased disease severity and a greater incidence of relapse. PKM2 depletion in macrophages enhanced intestinal barrier function and ameliorated colitis progression in mice. Mechanistically, PKM2 deficiency promoted monocyte differentiation into reparative Cadm1+ macrophages and enhanced Lgr5+ stem cell self-renewal via the PGE2/EP4 axis. Cross-species analysis revealed that human STAB1+ macrophages, which exhibit transcriptomic and metabolic similarities to mouse Cadm1+ macrophages, were positively associated with UC remission and spatial distribution of CD8+ T cells in colorectal cancer. Interestingly, macrophage PKM2 deletion greatly suppressed tumourigenesis in mice, accompanied by an increased abundance of Cadm1+ macrophages and enhanced CD8+ T-cell infiltration. Furthermore, targeting PKM2 in intestinal macrophages attenuated colitis progression in mice. CONCLUSIONS: Therapeutic targeting of PKM2-dependent glycolysis in macrophages enhanced Cadm1+ macrophage-mediated mucosal healing without driving tumourigenesis.
引用
- Zhang D, Tao P, Li J, et al. Targeting PKM2-dependent glycolysis reprogrammes monocytes into Cadm1+ macrophages to promote mucosal repair and attenuate colitis progression. Gut. 2026. PMID: 41986135. doi:10.1136/gutjnl-2025-337344
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。